Medicare Part D · Drug Costs 2027
Eliquis Medicare Cost 2027: $237.25 Is the Price Medicare Negotiated, Not What You Pay
If you take Eliquis, you already know the stakes: it is the blood thinner standing between you and a stroke or another clot, taken twice a day, with no skipping around a pharmacy bill. Here is what it actually costs on Medicare in 2027, the deductible, the month-by-month math, the $2,400 ceiling that ends your drug costs for the year, and the two programs that can cut your share to $14.40 or spread it across the calendar.
The quick answer
Does Medicare cover Eliquis? Yes, through Medicare Part D or a Medicare Advantage plan with drug coverage. Eliquis (apixaban) keeps its Medicare-negotiated price in 2027: $237.25 for a 30-day supply, up from $231 in 2026 after CMS's yearly inflation adjustment, and far below the $521 list price CMS reported before negotiation.
That negotiated price is what your plan works from, it is not your copay. What you pay is set by your plan's deductible (no more than $700 in 2027), its tier for Eliquis, and its copay or coinsurance. And whatever your plan's design, your out-of-pocket cost for covered Part D drugs stops at $2,400 in 2027. After that, covered drugs cost $0 for the rest of the year.
Does Medicare cover Eliquis?
Yes, but not through Original Medicare alone. Parts A and B do not cover a self-administered prescription like Eliquis that you pick up at a pharmacy. Coverage comes from a Medicare Part D plan or a Medicare Advantage plan that includes drug coverage, together, what this page calls Medicare drug coverage.
Eliquis has a protection most drugs do not. It was one of the first 10 drugs selected for the Medicare Drug Price Negotiation Program, and while a drug is in that program, Medicare drug plans must include it on their formularies. So for 2027, the question is rarely whether your plan covers Eliquis. It is what your plan charges for it, which tier it sits on, and whether you pay a flat copay or a percentage.
Eliquis is the brand name for apixaban, a factor Xa inhibitor made by Bristol Myers Squibb and Pfizer. It is prescribed to lower the risk of stroke in people with atrial fibrillation not caused by a heart-valve problem, and to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), including after hip or knee replacement. The usual dose is one tablet twice a day, which is why a 30-day supply is 60 tablets, and why running out is not a safe option. Stopping an anticoagulant early raises the risk of the very clot or stroke it was prescribed to prevent.
Eliquis cost per month: the five prices you will see quoted
Search "eliquis cost per month" and you will find numbers from $14.40 to over $600, all calling themselves the price. They are measuring different things. Here is each one, labeled:
| Figure | Amount | What it actually is |
|---|---|---|
| Medicare negotiated price, 2027 | $237.25 / 30 days | The Maximum Fair Price your plan and pharmacy work from in 2027. Not your copay. Was $231 in 2026; CMS adjusts it for inflation each year. |
| List price before negotiation | $521 / 30 days | The 2023 wholesale list price CMS used as its comparison when it announced the negotiated price, a 56% discount. Not what Medicare patients paid then or now. |
| What Medicare patients paid, on average | ~$45–$51 / month | Bristol Myers Squibb's published averages from claims (October 2024–September 2025): an average of $45–$51 a month, with half of Medicare patients paying $15–$30 or less. An average across plans and indications, not a quote for your plan, and it predates 2027 plan designs. |
| With Extra Help, 2027 | Up to $14.40 / fill | The most someone with full Extra Help pays for a brand-name drug like Eliquis in 2027, with a $0 deductible. As low as $5.00 with full Medicaid at lower income. |
| Cash, no coverage | ~$345 / 30 days | The manufacturers' Direct-to-Patient cash price for uninsured, self-paying patients (since September 2025; the published list price is $346). Retail cash prices vary widely by pharmacy. This program is not for people on Medicare, and cash bought outside your plan does not count toward your deductible or the $2,400 cap. |
Sources for this table are listed at the end of this page. Averages are labeled as averages wherever they appear, your plan's formulary is the only source that can price your own fill.
How much is Eliquis with Medicare? Run your year
Part D does not charge a steady monthly price. You pay more early in the year (the deductible), less in the middle (coinsurance or a copay), and nothing at all after the cap. This estimator walks a full year of Eliquis month by month using the real 2027 figures, the $237.25 negotiated price, your choice of deductible, and the $2,400 cap, so you can see the shape of your year before it happens.
It is an illustration built on the standard benefit, not a quote. Your plan may use a different deductible, copay, or coinsurance for Eliquis, and that design, printed in your plan's formulary, is what you will actually be charged.
Your 2027 Eliquis year, month by month
Eliquis is priced at the 2027 negotiated price of $237.25 per 30-day supply throughout. Premiums are not included, they never count toward the cap.
The defined standard benefit: full price until the deductible is met, then 25% of the drug's price.
$700 is the most any Part D plan may charge in 2027. Many charge less, and some apply no deductible to certain tiers. Check your Annual Notice of Change.
After your deductible is met. Copays vary widely by plan and tier, use the figure in your plan's formulary or Evidence of Coverage.
Other prescriptions count toward the same deductible and the same $2,400 cap. Add their monthly plan price here to see when the cap arrives.
The payment plan bills you monthly instead of at the counter. Same total, smoother months. Details below.
How this is figured: each month you pay the full plan price of your covered drugs until your deductible is met, then your copay or 25% coinsurance, until everything you have paid reaches $2,400, then $0. Extra Help mode uses the 2027 full-subsidy rules: $0 deductible and no more than $14.40 per Eliquis fill (other drugs are not modeled in that mode). The payment-plan view assumes you opt in before January and uses Medicare's billing formula; it changes timing, never the total.
The deductible, then the cap: how a year on Eliquis actually unfolds
Since the Part D redesign, the year has three stages, there is no donut hole anymore. For 2027, CMS set the numbers in its CY 2027 Rate Announcement (April 6, 2026):
| Standard benefit | 2026 | 2027 |
|---|---|---|
| Maximum deductible | $615 | $700 |
| Cost sharing after the deductible (standard) | 25% | 25% |
| Annual out-of-pocket cap | $2,100 | $2,400 |
| After the cap | $0 | $0 |
| National base beneficiary premium (a calculation benchmark, not your plan's premium) | $38.99 | $41.33 |
- Stage 1, the deductible (up to $700)You pay the full plan price of covered drugs until you have paid your plan's deductible. On Eliquis alone at $237.25 a month, a full $700 deductible takes parts of three fills to clear, which is why January and February feel so expensive. The $700 is a ceiling, not a requirement: no plan may charge more, many charge less, and some charge nothing on certain tiers.
- Stage 2, initial coverage (25% in the standard benefit)Once the deductible is met, the standard design charges 25% of the drug's price. For Eliquis that is about $59 a month, a useful check on any plan quote. Many real plans replace the 25% with a flat copay or a different percentage for Eliquis's tier, which is why the manufacturer's reported averages ($45–$51 a month) land a little below the standard-benefit figure.
- Stage 3, the cap ($2,400), then $0Everything you paid in stages 1 and 2 counts toward $2,400. The moment your out-of-pocket spending on covered drugs reaches it, you pay nothing more for covered drugs for the rest of 2027. On Eliquis alone under the standard benefit, the year totals about $1,237, under the cap, so the cap never arrives. Add other brand-name drugs and it can arrive by summer; from that month on, every covered fill is $0.
What counts toward the $2,400, and what does not. Your deductible, copays, and coinsurance for drugs your plan covers count, and so do certain amounts paid on your behalf, such as through Extra Help. Your monthly premium does not count. Neither do drugs your plan does not cover, or drugs you buy outside your plan, one more reason a cash "deal" on Eliquis can quietly cost you progress toward $0 months later in the year.
Where Eliquis sits on the formulary: tiers
Every plan sorts its drug list into tiers, and the tier sets your price. Eliquis is a brand-name drug with no generic, so plans typically place it on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), depending on the plan. Tier 3 and 4 drugs are commonly charged as coinsurance, a percentage of the price, rather than a small flat copay, which is exactly why the negotiated price matters to you: 25% of $237.25 is about $59, while 25% of the old $521 list price would have been about $130. Some plans add rules such as prior authorization or quantity limits; your plan's formulary shows Eliquis's tier and any rules next to its name.
Eliquis and the Medicare negotiated price in 2027
Eliquis was one of the first 10 drugs Medicare ever negotiated, chosen because Part D spent more on it than on any other drug, about $18.3 billion for roughly 3.9 million people in the period CMS reported. The negotiation cut the 30-day price from a $521 list price to $231 for 2026. For 2027, CMS's negotiated-price file sets it at $237.25, the same negotiated price, adjusted upward for inflation the way the program does each year. It is still roughly 54% below that $521 comparison price.
Two things the negotiated price does not do, because both misunderstandings are everywhere:
- It is not your copay. It is the price inside your plan's math. Your deductible, tier, and copay or coinsurance decide your share of it, and the $2,400 cap limits your year no matter what.
- It did not disappear for 2027. Four of the first 10 negotiated drugs, Xarelto, Entresto, Stelara, and NovoLog/Fiasp, leave the program on January 1, 2027 because generic or biosimilar competition arrived. Eliquis is not one of them: CMS lists no removal for Eliquis, so its negotiated price, and the requirement that plans keep it on their formularies, carries through 2027. If you have read our Xarelto Medicare coverage 2027 guide, this is the fork in the road between the two blood thinners: Xarelto lost its negotiated price; Eliquis kept its.
Why there is no generic Eliquis yet, and when there will be
This is the question underneath every Eliquis bill: apixaban has been on the market since 2012, so where is the cheap generic? The honest answer is that the generics exist, they are sitting in a legal waiting room.
- The FDA approved the first generic apixaban applications in December 2019, and about 13 generic versions are now approved. None can be sold in the U.S. yet.
- Two patents control the timeline. The patent on the apixaban molecule itself expires in November 2026 (May 2027 with its pediatric extension). A second, formulation patent, covering how the tablet is made, is listed in the FDA Orange Book through August 2031.
- Settlements set the launch date. Bristol Myers Squibb and Pfizer sued the generic makers, the courts upheld the patents, and the settlements that followed allow generic launches starting April 1, 2028, more than three years before the formulation patent expires, but not one day sooner under those agreements.
So for all of 2027, Eliquis is brand-only in the United States, and the negotiated price plus the $2,400 cap are the protections you have. Plan on April 2028 as the earliest generic date, and be skeptical of any site promising a U.S. generic sooner, or of "generic Eliquis" sold by overseas websites: that is not the FDA-approved generic, and buying it outside your plan leaves you without the cap's protection and without any guarantee of what is in the tablet.
Too much at once? The Medicare Prescription Payment Plan
The hardest part of the Part D year is not the total, it is the shape. A $700 deductible lands in the first weeks of January, on top of every other January bill. The Medicare Prescription Payment Plan exists for exactly that problem. It works with your current drug coverage:
- You pay $0 at the pharmacy for covered drugs, and your plan sends you a monthly bill instead.
- Your bill spreads what you owe across the months left in the year. In 2027 the most it can ever spread is the $2,400 cap, someone who hit the full cap in January and opted in beforehand would be billed $200 a month.
- It is free to join, has no interest and no income test, and you opt in through your drug plan. Enrollment now renews automatically each year unless you opt out.
- It does not lower what you pay. Medicare says so plainly: it changes when you pay, not how much. The estimator above shows both shapes side by side, same total, different months.
It helps most when your drug costs land early in the year, the classic Eliquis pattern. It helps least if you join late in the year (fewer months to spread across) or if you have Extra Help, which already keeps each fill at $14.40 or less. Try the "Spread monthly" view in the estimator to see your own months.
Extra Help: the version of this page where Eliquis costs $14.40
If your income and savings are limited, stop optimizing tiers and check this first. Extra Help, the Part D Low-Income Subsidy, run through Social Security, is worth more than any plan-shopping trick on this page. With full Extra Help in 2027:
- Your Part D deductible is $0, and your premium is $0 in a plan priced at or below your area's benchmark.
- You pay no more than $14.40 for a brand-name drug like Eliquis and $5.80 for a generic, per fill. If you also have full Medicaid and income at or below the poverty level, the brand-name maximum is $5.00.
- Amounts paid on your behalf still count toward the $2,400 cap, after which covered drugs are $0.
For scale: the 2026 limits were income up to about $23,940 a year for an individual ($32,460 for a couple) and resources up to $18,090 ($36,100 for a couple), and people with Medicaid, SSI, or a Medicare Savings Program are enrolled automatically. You can apply any time through Social Security, approval also gives you a Special Enrollment Period to change drug plans outside the fall window. Our Medicare Extra Help guide walks through what counts as income and resources.
Still open: the 2027 Extra Help limits
CMS has published the 2027 Extra Help copays ($5.80 / $14.40) in its CY 2027 Rate Announcement, but the 2027 income and resource limits had not been published as of this writing, they follow the new federal poverty guidelines and a CMS memo that comes later. Until they appear, the 2026 limits above are the planning figures. If you were close to the line in 2026, apply anyway: the application is free, and the limits generally rise each year.
One card you cannot use: the Eliquis copay card that brings commercially insured patients down to $10 a fill is not available to you on Medicare. Federal anti-kickback rules bar manufacturer copay cards with Medicare, Medicaid, and other government coverage, any site or coupon promising to stack it with Part D is steering you wrong. Extra Help, the cap, and the payment plan are the Medicare-legal versions of the same help. (The Bristol Myers Squibb Patient Assistance Foundation is a separate charitable program with its own income rules, worth asking about if you are uninsured, and it does not replace Part D.)
What to do if your plan's formulary drops Eliquis, or moves it
Because Eliquis stays in the negotiation program for 2027, plans must keep it on their formularies. What can change on January 1 is its tier, its copay or coinsurance, or rules like prior authorization, and a move from Tier 3 to Tier 4 can raise your cost more than any headline about the drug itself. If your Annual Notice of Change (mailed in the fall) shows a change, work this list in order:
- Compare plans before December 7Annual Enrollment runs October 15 to December 7, 2026 for 2027 coverage. A different plan may price Eliquis a full tier lower. Compare total yearly cost, premium plus drug costs, not the premium alone. Our Part D in 2027 guide explains what else changed for 2027 plans.
- Ask for a tiering exceptionIf Eliquis moved to a higher tier, you or your prescriber can ask the plan to charge you the lower tier's cost. Your prescriber must state why the lower-tier alternatives would not work for you, for an anticoagulant, a documented history with the alternatives is exactly the kind of reason this process exists for.
- If a drug is ever removed: formulary exception + transition fillFor a drug taken off a formulary entirely, the route is a formulary exception with your prescriber's supporting statement, and an appeal if it is denied. While that is decided, the plan's transition process gives you a temporary 30-day supply in the first 90 days of the plan year (91 days in a long-term care facility) so you are not cut off mid-treatment.
- Do not ration or stop Eliquis on your ownSkipping doses of an anticoagulant to stretch a supply raises your risk of stroke or a new clot, the events the drug is preventing. If cost is the problem, call your prescriber, your plan, or us before you miss a dose. Between exceptions, the payment plan, and Extra Help, there is almost always a lever that does not involve gambling with a clot.
Before December 7: your Eliquis checklist
- Find Eliquis in your plan's 2027 formulary: note the tier, the copay or coinsurance, and any prior-authorization or quantity-limit rules.
- Check your Annual Notice of Change for a tier move or a deductible change on your current plan.
- Run your full drug list, not just Eliquis, through a 2027 plan comparison, and compare total yearly cost. Other drugs decide when your $2,400 cap arrives.
- If your income is anywhere near the Extra Help limits, apply through Social Security before you settle for a higher-cost plan.
- If January's deductible is the problem, opt in to the Medicare Prescription Payment Plan through your plan before the year starts.
- Make any plan change by December 7, 2026, it takes effect January 1, 2027.
Eliquis Medicare Part D: questions, answered straight
Does Medicare cover Eliquis?
Yes, through Medicare Part D or a Medicare Advantage plan with drug coverage, not through Original Medicare (Parts A and B) on its own. Eliquis was one of the first 10 drugs in Medicare's price negotiation program, and drug plans must include negotiated drugs like Eliquis on their formularies while the drug is in the program. Your cost still depends on your plan's tier, deductible, and copay or coinsurance for Eliquis.
How much is Eliquis with Medicare in 2027?
It depends on your plan and where you are in the year. Medicare's negotiated price for a 30-day supply is $237.25 in 2027, that is the price your plan works from, not your copay. Under the standard Part D benefit (a $700 deductible, then 25% coinsurance), Eliquis alone works out to about $1,237 for the year. Bristol Myers Squibb's published averages put what Medicare patients actually paid at about $45 to $51 a month in recent claims data, and no one with Part D pays more than $2,400 out of pocket for covered drugs in 2027.
What is the Eliquis cost per month on Medicare Part D?
There is no single monthly price, because Part D costs change as you move through the year. In the standard benefit for 2027, you pay the full negotiated price until your deductible is met, up to $700, then 25% of $237.25, which is about $59 a month, until your out-of-pocket spending reaches the $2,400 cap. After the cap, Eliquis and your other covered drugs cost $0 for the rest of the year. Many plans use a flat copay or a different coinsurance percentage instead, so check your own plan's formulary.
Does the $237.25 negotiated price mean I pay $237.25 a month?
No. $237.25 is the Maximum Fair Price, the negotiated price for a 30-day supply that Medicare drug plans and pharmacies work from in 2027, up from $231 in 2026 after CMS's yearly inflation adjustment. What you pay at the counter is set by your plan: your deductible first, then your copay or coinsurance, and never more than $2,400 out of pocket for covered drugs in 2027.
Is there a generic Eliquis (apixaban)?
Not for sale in the United States yet. The FDA approved the first generic apixaban applications in December 2019, but patent litigation settlements between Bristol Myers Squibb, Pfizer, and the generic makers set the earliest U.S. launch date at April 1, 2028. A formulation patent listed in the FDA Orange Book runs to August 2031, and the settlements let generic makers launch before it expires. Until April 2028, Eliquis is brand-only in the U.S.
Can I use the Eliquis $10 copay card with Medicare?
No. The manufacturer's copay card is for people with commercial insurance only. Federal rules do not allow manufacturer copay cards to be used with Medicare, Medicaid, or other government coverage. If you have Medicare, the routes that lower your Eliquis cost are Extra Help, the $2,400 annual cap, the Medicare Prescription Payment Plan for spreading costs, and choosing a plan whose formulary prices Eliquis well.
How does Extra Help change what I pay for Eliquis?
A lot. With full Extra Help (the Part D Low-Income Subsidy) in 2027, you pay no Part D deductible, your premium is $0 in a plan at or below your area's benchmark, and you pay no more than $14.40 for a brand-name drug like Eliquis, $5.80 for a generic. People who also have full Medicaid and income at or below the poverty level pay no more than $5.00 for a brand-name drug. Apply through Social Security.
What if my plan drops Eliquis or moves it to a higher tier?
First, check the Annual Notice of Change your plan sent in the fall, it lists formulary and tier changes for January 1. While Eliquis stays in the negotiation program, plans must keep it on their formularies, but its tier and cost sharing can still change. Your options: switch plans during Annual Enrollment (October 15 to December 7, 2026, for 2027 coverage); ask your plan for a tiering exception or formulary exception with a supporting statement from your prescriber; and use the transition fill, a temporary 30-day supply in the first 90 days of the year, while an exception is decided. Do not stop taking Eliquis to save money without talking to your prescriber first.
What happens after I reach the $2,400 cap?
You pay $0 for covered Part D drugs for the rest of 2027. The $2,400 cap counts what you pay for covered drugs, your deductible, copays, and coinsurance, plus certain amounts paid on your behalf, such as through Extra Help. It does not count your monthly premiums or drugs your plan does not cover. The count resets on January 1.
Want a licensed agent to price Eliquis in the 2027 plans in your county?
Formularies differ plan by plan, and the cheapest premium is often not the cheapest year. Call Senior Benefit Assistance and we will check where Eliquis sits in each plan available to you, run your full drug list against the $2,400 cap, and screen you for Extra Help, before the December 7 deadline.
Call 1-866-340-3441 (TTY 711)Senior Benefit Assistance is a licensed Medicare agency. This page is educational and is not medical advice, talk to your doctor or pharmacist before changing any medication.
Sources
Every figure on this page traces to one of these. Averages are the manufacturer's published figures and are labeled as averages in the text; plan-specific costs come only from your own plan's formulary.
- CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026, Eliquis Maximum Fair Price $231 per 30-day supply vs. $521 list price (56% discount); about $18.28 billion in Part D spending and 3,928,000 enrollees.
- CMS Selected Drug List and Maximum Fair Price data file (September 21, 2026), as reported in WLB Insurance Group, "Negotiated drug prices: what they change and what they don't" and "How much does Eliquis cost on Medicare in 2027?", Eliquis negotiated price $237.25 from January 1, 2027; no deselection for Eliquis (Xarelto, Entresto, Stelara, NovoLog/Fiasp are deselected).
- CMS, Announcement of Calendar Year (CY) 2027 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies (April 6, 2026), 2027 standard deductible $700, out-of-pocket threshold $2,400, 25% standard coinsurance, Extra Help copay maximums $5.80 / $14.40; summarized in Goodsurance, "Medicare Part D 2027: Deductible, Out-of-Pocket Cap, and Premium".
- Medicare.gov, "How much does Medicare drug coverage cost?", the three coverage stages, the $700 (2027) deductible ceiling, the $2,400 (2027) cap, and that the payment plan "doesn't save you money or lower your drug costs."
- Bristol Myers Squibb Eliquis pricing information (claims, October 2024–September 2025), as compiled in Pharma Giant, "Eliquis Cost 2026", Medicare patients paid an average of $45–$51 a month, half paying $15–$30 or less; Direct-to-Patient cash price $345 (list price $346).
- Grants Hub USA, "Extra Help Medicare: 2026 Income Limits, 2027 Copays", 2027 Extra Help copays $5.80 / $14.40 set in the CMS CY 2027 Rate Announcement; 2026 income limits $23,940 / $32,460 and resource limits $18,090 / $36,100.
- Benefit Bull, "Medicare Prescription Payment Plan 2027", based on CMS Product No. 12211 (September 2026), how the payment plan bills monthly, the $2,400 ceiling on what it can spread, and the billing formula.
- FDA Orange Book and patent-litigation settlements, as tracked by HelloPharmacist, "When Will Eliquis Go Generic?", first generic approvals December 2019, formulation patent to August 2031, earliest U.S. generic launch April 1, 2028.
- Senior Benefit Assistance, "Xarelto Medicare Coverage 2027: Costs & Generic Options", the companion guide on the other major blood thinner, whose negotiated price ends in 2027.
Senior Benefit Assistance · By Jordan Diaz · Published November 18, 2026. Figures verified against CMS, Medicare.gov, and manufacturer sources as of publication; Part D amounts are set annually and plan-specific costs vary. This page is general education about Medicare drug costs, not a quote, not medical advice, and not a substitute for your plan's Evidence of Coverage. We do not offer every plan available in your area; contact Medicare.gov or 1-800-MEDICARE for information on all of your options.